Which emerging areas of movement disorders research are set to advance in the coming years? And how is that already beginning to affect clinical care? Prof. Jose Obeso shares about this and other key scienctific shifts with Prof. Tiago Outeiro.

The lines between functional and organic are blurring, as a promising opportunity to develop outcome measurements arises. Dr. Alberto Espay discusses with Dr. Sara Schaefer these and other advancements in functional movement disorders.

Promising results on potential treatments, biomarkers, genetic predictors and more in dystonia were presented at the MDS Congress. Dr. Florence Chang highlights the key takeaways with Dr. Hugo Morales.

New updates to MSA criteria and clinical evaluation tools will have a critical impact on MSA care and research. Dr. Maria Teresa Pellecchia discusses with Dr. Eduardo de Pablo-Fernández the next major areas of focus, and the progression of a variety of clinical trials.

Wearable sensors, electronic rating scales, eDiaries — Dr. Álvaro Sánchez-Ferro discusses with Dr. Michele Matarazzo how these and a broad range of other emerging digital technologies can help take movement disorder evaluation outside the clinic and into patients' everyday environment.

"A Multi-Step Model of Parkinson's Disease Pathogenesis" was awarded "Best Research Article of the Movement Disorders journal for 2022." Dr. Michele Matarazzo interviews the first author, Dr. Campbell Le Heron. Read the article

A re-release of the episode featuring the recently-awarded "Best Review article of 2022 from the Movement Disorders journal" article, titled "The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy." Read the article.

Dr. Eduardo de Pablo-Fernández speaks with Dr. Dilan Athauda about his recent paper, "The impact of type 2 diabetes in Parkinson's disease" recently published in Movement Disorders. They discuss the clinical impact of type 2 diabetes in the phenotype and disease progression and the therapeutic implications of this association. Read the article.

Dr. Sara Schaefer speaks with Drs. Gregoire Courtine and Jocelyne Bloch about the use of an implanted spinal cord stimulator for the treatment of orthostatic hypotension in multiple-system atrophy.

Read the article.

Dr. Hilmar Sigurdsson shares the results of an FDG PET study that found 2 distinct patterns of brain metabolism related to gait disfunction in PD, suggesting that this objective measure could help better understand the neural basis of gait disorders and could also be used to predict gait involvement in clinical practice and as outcome measure in clinical trials. Read the article.